Brown Shipley & Co’s Thermo Fisher Scientific TMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$5.27M Buy
+10,509
New +$5.04M 2.73% 12
2026
Q1
Sell
-10,920
Closed -$6.33M 81
2025
Q4
$6.33M Sell
10,920
-504
-4% -$285K 3.38% 11
2025
Q3
$5.54M Sell
11,424
-401
-3% -$187K 2.93% 13
2025
Q2
$4.79M Sell
11,825
-332
-3% -$139K 2.64% 12
2025
Q1
$6.05M Sell
12,157
-410
-3% -$222K 3.43% 11
2024
Q4
$6.54M Sell
12,567
-673
-5% -$370K 3.25% 11
2024
Q3
$8.19M Sell
13,240
-3,210
-20% -$1.9M 4.03% 10
2024
Q2
$9.1M Buy
16,450
+425
+3% +$243K 4.1% 9
2024
Q1
$9.25M Buy
16,025
+1,685
+12% +$946K 2.91% 13
2023
Q4
$7.61M Buy
14,340
+834
+6% +$404K 3.77% 11
2023
Q3
$6.84M Buy
13,506
+1,152
+9% +$614K 3.77% 9
2023
Q2
$6.45M Buy
12,354
+1,189
+11% +$642K 2.64% 12
2023
Q1
$6.44M Buy
+11,165
New +$6.29M 4.15% 5

Other funds holding TMO

Brown Shipley & Co's TMO Position: Q2 2026 in Review

Brown Shipley & Co opened a new position in Thermo Fisher Scientific (TMO) in Q2 2026: 10,509 shares worth $5.27M. The stake represents 2.73% of the portfolio and ranks #12 among its holdings. This is a return to the name: Brown Shipley & Co previously reported a position in TMO as recently as Q4 2025.

Brown Shipley & Co first reported a position in TMO in Q1 2023 and has held it in 13 quarters since. The position peaked at $9.25M in Q1 2024. 1,172 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

  • Brown Shipley & Co held 10,509 shares of Thermo Fisher Scientific worth $5.27M as of Q2 2026.
  • Thermo Fisher Scientific was a new Brown Shipley & Co position in Q2 2026.
  • Thermo Fisher Scientific made up 2.73% of Brown Shipley & Co's portfolio in Q2 2026, its #12 holding.
  • Brown Shipley & Co first reported a position in Thermo Fisher Scientific in Q1 2023 and has held it in 13 quarters since.
  • Brown Shipley & Co's Thermo Fisher Scientific position peaked at $9.25M in Q1 2024.
  • 1,172 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on Brown Shipley & Co's 13F filing for Q2 2026, filed 14 Jul 2026.